QBE Insurance Group Limited releases full-year results: Is it time to buy?

The question for investors is whether the upside potential outweighs the downside risks.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Yesterday QBE Insurance Group Ltd (ASX: QBE) released its full-year results for 2013. While the results were far from spectacular, the absence of any further bad news was such a relief for investors that they sent the stock up 5.3% to $12.27. Here are the key facts investors need to know.

Top line ok but bottom line poor

Net earned premium fell 3% to US$15.4 billion which wasn't too bad considering the headwinds, however the underwriting performance was "impacted by prior accident year claims and one-off costs" which led to a 25% drop in underwriting profit from US$453 million in 2012 to US$341 million. Adding in investment income generated from policy holder funds of US$500 million and the insurance operations generated an insurance profit of US$841 million, a decline of 33% on the $1.26 billion in 2012.

At the bottom line, cash profit fell 27% to US$761 million from US$1 billion the prior year; while after impairments and amortisation the company reported a net loss after tax of US$254 million.

North American operations continue to cause headaches

The results from the North American (NA) operations were disappointing and largely to blame for the overall poor performance of the group. The specialist units of crop protection and financial partners services (FPS) were a particular drag. Overall the North American division recorded prior year accident claims of US$412 million, restructuring and other costs of a further $134 million and an insurance loss of US$445 million.

While the North American division received much of the attention, both the Latin American and European divisions also recorded significant declines in insurance profit. These two divisions saw profit declines of 18% and 41% respectively.  In comparison the ANZ, Asia Pacific and Equator divisions produced respectable results.

Foolish takeaway

With just US$4.75 in tangible book value and a balance sheet which is 44% geared there are still plenty of reasons for investors to be wary of QBE. However, investors prepared to take a contrarian view and assume that the combined operating ratio, return on equity and interest rates can all 'revert to the mean', can arguably see there is potential upside in the stock.

Motley Fool contributor Tim McArthur owns shares in QBE Insurance.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »